Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
Background
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Items 501–600 of 1,000
High rate of HSV-1 reactivation in invasively ventilated COVID-19 patients: Immunological findings
Seeßle, J., Hippchen, T., Schnitzler, P., Gsenger, J., Giese, T., & Merle, U. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254129 · Cited by 52
“Type I interferons (IFNs) are key components in the antiviral response and inhibit viral replication through type-I IFN receptor (IFNAR) signaling and initiate transcription of hundreds of ISGs that have antiviral, immune modulatory, and cell regulatory functions [26].”
BackgroundAn integrated transcriptomic cell atlas of human endoderm-derived organoids
Xu, Q., Halle, L., Hediyeh-zadeh, S., Kuijs, M., Riedweg, R., Kilik, U., Recaldin, T., Yu, Q., Rall, I., Frum, T., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02182-6 · Cited by 53
Morphine Withdrawal Enhances Hepatitis C Virus Replicon Expression
Wang, C., Li, Y., Douglas, S. D., Wang, X., Metzger, D. S., Zhang, T., & Ho, W. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61220-5 · Cited by 45
Replication of Respiratory Syncytial Virus Is Inhibited by the Host Defense Molecule Viperin
McGillivary, G., Jordan, Z. B., Peeples, M. E., & Bakaletz, L. O. (2012) · Journal of Innate Immunity · doi:10.1159/000342473 · Cited by 45
Bhattacharya, S., HuangFu, W.-C., Liu, J., Veeranki, S., Baker, D. P., Koumenis, C., Diehl, J. A., & Fuchs, S. Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071498 · Cited by 45
Mostafavi, H., Abeyratne, E., Zaid, A., & Taylor, A. (2019) · Viruses · doi:10.3390/v11030290 · Cited by 47
“Induction of type I IFN (IFN-α/β) is a hallmark of the innate immune response to viral infection [12,13].”
BackgroundNakawesi, J., This, S., Hütter, J., Boucard-Jourdin, M., Barateau, V., Muleta, K. G., Gooday, L. J., Thomsen, K., López, A. G., Ulmert, I., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0276-8 · Cited by 47
Kropp, K. A., Robertson, K. A., Sing, G. K., Rodriguez-Martin, S., Blanc, M., Lacaze, P. A., Hassim, M. F. N., Khondoker, M. R., Busche, A., Dickinson, P., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00373-11 · Cited by 48
A Tug of War: Pseudorabies Virus and Host Antiviral Innate Immunity
Ye, G., Liu, H., Zhou, Q., Liu, X., Huang, L., & Weng, C. (2022) · Viruses · doi:10.3390/v14030547 · Cited by 47
Recognizing the Importance of Respiratory Syncytial Virus in Chronic Obstructive Pulmonary Disease
Ramaswamy, M., Groskreutz, D. J., & Look, D. C. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550902724024 · Cited by 44
“This group of interferons activate many antiviral genes, particularly genes involved in establishment of a host cell antiviral state such as MxA, protein kinase R (PKR), 2′-5′oligoadenylate synthetase, and interferon regulatory factor7 (78).”
BackgroundDevelopment of a transmission model for dengue virus
Christofferson, R. C., McCracken, M. K., Johnson, A.-M., Chisenhall, D. M., & Mores, C. N. (2013) · Virology Journal · doi:10.1186/1743-422x-10-127 · Cited by 44
“IFN-α and -β are responsible for the establishment and maintenance of the anti-viral state in the immune response [8-10,14,15].”
BackgroundHuarte, E., Larrea, E., Hernández-Alcoceba, R., Alfaro, C., Murillo, O., Arina, A., Tirapu, I., Azpilicueta, A., Hervás-Stubbs, S., Bortolanza, S., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.02.015 · Cited by 44
“Type I IFNs are polypeptides discovered for their ability to interfere with viral infection of cell cultures [1].”
BackgroundRIG-I-Like Receptors Mediate Innate Antiviral Response in Mouse Testis
Zhu, W., Chen, Q., Yan, K., Liu, Z., Li, N., Zhang, X., Yu, L., Chen, Y., & Han, D. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1075 · Cited by 43
Role of interferons in the treatment of severe acute respiratory syndrome
Cinatl, J. J., Michaelis, M., Scholz, M., & Doerr, H. W. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.6.827 · Cited by 44
“Although in virally infected cells both IFNs and viral dsRNA can contribute to the induction of ISGs, in some cases mere binding of viral envelope proteins to the cell surface receptors can trigger transcription of specific ISGs.”
BackgroundMethodInfluentialPositive selection on apoptosis related genes
da Fonseca, R. R., Kosiol, C., Vinař, T., Siepel, A., & Nielsen, R. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.12.022 · Cited by 42
“Molecules such as interleukins (IL) and interferons (IFNs, involved in inflammatory responses) occur early in the signaling cascades [3,4].”
BackgroundPro-Viral and Anti-Viral Roles of the RNA-Binding Protein G3BP1
Jayabalan, A. K., Griffin, D. E., & Leung, A. K. L. (2023) · Viruses · doi:10.3390/v15020449 · Cited by 47
Emergence, phylogeography, and adaptive evolution of mpox virus
Guan, H., Gul, I., Xiao, C., Ma, S., Liang, Y., Yu, D., Liu, Y., Liu, H., Zhang, C. Y., Li, J., et al. (2023) · New Microbes and New Infections · doi:10.1016/j.nmni.2023.101102 · Cited by 52
“Interferons (IFNs), a family of cytokines that inhibits viral replication, are one of the key effectors of the innate immune response [11,12].”
Liu, B., Janssen, H. L. A., & Boonstra, A. (2012) · European Journal of Immunology · doi:10.1002/eji.201142360 · Cited by 44
Liu, Y., Zhang, Z., Zhao, X., Yu, R., Zhang, X., Wu, S., Liu, J., Chi, X., Song, X., Fu, L., et al. (2014) · Viral Immunology · doi:10.1089/vim.2013.0127 · Cited by 45
Monsurrò, V., Beghelli, S., Wang, R., Barbi, S., Coin, S., Pasquale, G. D., Bersani, S., Castellucci, M., Sorio, C., Eleuteri, S., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-10 · Cited by 47
“First, no genes encoding for any known type I IFNs were observed to be up-regulated in association with the “anti-viral state” or the down-stream activation of ISGs; although type one IFN expression is not an absolute requirement for ISG activation during cytomegalovirus infection [36], this IFN-independent activation…”
BackgroundThe host cytosol: front-line or home front?
O’Riordan, M. X. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02401-0 · Cited by 42
Malur, M., Gale, M., & Krug, R. M. (2012) · Journal of Virology · doi:10.1128/jvi.00510-12 · Cited by 43
“Here we measured the production of IFN by assaying for activation (phosphorylation) of STAT1, the transcription factor activated by IFN (3, 5).”
MethodSelf-citationPirooz, S. D., He, S., Zhang, T., Zhang, X., Zhao, Z., Oh, S., O’Connell, D., Khalilzadeh, P., Amini-Bavil-Olyaee, S., Farzan, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320629111 · Cited by 41
“How does UVRAG promote viral infection? A simple interpretation would be an altered type I IFN response, the first line of defense against virus infection (13).”
BackgroundCurrent concepts on immunopathogenesis of hepatitis B virus infection
Peeridogaheh, H., Meshkat, Z., Habibzadeh, S., Arzanlou, M., Mohammadshahi, J., Rostami, S., Gerayli, S., & Teimourpour, R. (2017) · Virus Research · doi:10.1016/j.virusres.2017.12.007 · Cited by 49
Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity
Persano, S., Das, P., & Pellegrino, T. (2021) · Cancers · doi:10.3390/cancers13112735 · Cited by 43
“In a different study, the use of amino-modified ferumoxytol was proposed for intratumoral delivery of TLR3-agonist poly(I:C) [120].”
BackgroundInfluenza A virus induces p53 accumulation in a biphasic pattern
Yang, S., Wang, X., Guo, L., Qiu, Y., Li, X., Yu, H., Xiang, H., Tong, G., & Ma, Z. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.018 · Cited by 41
Huang, H.-N., Pan, C., Rajanbabu, V., Chan, Y.-L., Wu, C., & Chen, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.061 · Cited by 41
“4) [35].”
Wang, K. C., Chang, J., Chiang, L. C., & Lin, C. C. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.02.016 · Cited by 43
Deschamps, S., Meyer, J., Chatterjee, G., Wang, H., Lengyel, P., & Roe, B. A. (2003) · Genomics · doi:10.1016/s0888-7543(03)00092-2 · Cited by 41
Urosevic, M., Fujii, K., Calmels, B., Laine, E., Kobert, N., Acres, B., & Dummer, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32077 · Cited by 42
Le‐Trilling, V. T. K., Trilling, M., Zimmermann, A., & Hengel, H. (2008) · Journal of General Virology · doi:10.1099/vir.0.83538-0 · Cited by 41
“Viral antagonists of IFN-b gene induction, IFN receptor signal transduction and the action of antiviral effector proteins have been identified (Katze et al., 2002; Hengel et al., 2005).”
Banerjee, A., Rapin, N., Miller, M. R., Griebel, P. J., Zhou, Y., Munster, V. J., & Misra, V. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.09.008 · Cited by 40
“An early interferon response is known to inhibit replication of some viruses (Katze et al., 2002) .”
Zou, Y., Wang, Y., Deng, Y., Cao, Z., Li, S., & Wang, J. (2017) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-017-0182-4 · Cited by 51
“The tumor necrosis factor participates in cell mediated immune response [48] and plays an important role in resisting and defending against intracellular viruses and mycoplasma [49, 50].”
BackgroundPathogenesis and Mechanism of Gastrointestinal Infection With COVID-19
Zhang, H., Shao, B., Dang, Q., Chen, Z., Zhou, Q., Luo, H., Yuan, W., & Sun, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674074 · Cited by 48
Antiviral Activities of Interleukin-27: A Partner for Interferons?
Amsden, H., Kourko, O., Roth, M., & Gee, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.902853 · Cited by 41
Therapeutic application of RNA interference for hepatitis C virus
Watanabe, T., Umehara, T., & Kohara, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.022 · Cited by 48
Interleukin-2, interleukin-12, and interferon-γ levels and risk of young adult Hodgkin lymphoma
Cozen, W., Gill, P. S., Salam, M. T., Nieters, A., Masood, R., Cockburn, M., Gauderman, W. J., Martı́nez-Maza, O., Nathwani, B. N., Pike, M. C., et al. (2007) · Blood · doi:10.1182/blood-2007-08-106872 · Cited by 41
Koetzner, C. A., Kuo, L., Goebel, S. J., Dean, A. B., Parker, M. M., & Masters, P. S. (2010) · Journal of Virology · doi:10.1128/jvi.00385-10 · Cited by 49
“The E3L virus is highly sensitive to IFN because it lacks a dsRNA binding protein that inhibits PKR and OAS, in part by sequestering dsRNA (19, 33, 43).”
BackgroundInfluentialGupta, S., Ramesh, J., Bin, Q., Luciw, P. A., Greer, C. E., Perri, S., Legg, H. S., Donnelly, J., Barnett, S. W., O’Hagan, D. T., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7135-7145.2005 · Cited by 40
Brockmeier, S. L., Loving, C. L., Nelson, E. A., Miller, L. C., Nicholson, T. L., Register, K. B., Grubman, M. J., Brough, D. E., & Kehrli, M. E. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05490-11 · Cited by 39
“They contribute to innate antiviral immunity by promoting production of antiviral mediators such as PKR (double-stranded RNA-dependent protein kinase) and Mx (myxovirus resistant; IFN-inducible GTPase) and elicit NK cell activity for the killing of virus-infected cells (2, 3, 13, 27).”
BackgroundWeiss, G., Rasmussen, S., Fink, L. N., Jarmer, H. Ø., Nielsen, B. N., & Frøkiær, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011065 · Cited by 42
“IL-12 is at least partly induced by interferon (IFN)-b, a key inducer of a strong adaptive immune response against virus infections initiating a signaling cascade that controls the expression of hundreds of interferon-stimulated genes (ISGs) involved in an innate host response against viruses [12].”
Mechanisms of Borrelia burgdorferi internalization and intracellular innate immune signaling
Petnicki‐Ocwieja, T., & Kern, A. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00175 · Cited by 39
Galligan, C. L., Murooka, T. T., Rahbar, R., Baig, E. R., Majchrzak-Kita, B., & Fish, E. N. (2006) · Immunologic Research · doi:10.1385/ir:35:1:27 · Cited by 39
“An obvious target has been the type I IFN system, with many viruses encoding some form of IFN antagonist (49,50).”
BackgroundTan, H. T., Derrick, J., Hong, J., Sanda, C., Grosse, W. M., Edenberg, H. J., Taylor, M. W., Seiwert, S. D., & Blatt, L. M. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.632 · Cited by 39
“As these same processes and components have been implicated previously as primary drivers for direct anti-viral action and apoptosis, and consequently for viral clearance, (2,50–52) the methods used to identify genetic regulatory events as important determinants of viral clearance were supported.”
Arens, R. (2012) · Advances in immunology · doi:10.1016/b978-0-12-396548-6.00009-3 · Cited by 38
Dendritic cells and Mycobacterium tuberculosis: which is the Trojan horse?
Herrmann, J., & Lagrange, P. H. (2004) · Pathologie Biologie · doi:10.1016/j.patbio.2004.01.004 · Cited by 54
Induction and Function of IFNβ During Viral and Bacterial Infection
Nagarajan, U. M. (2011) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v31.i6.20 · Cited by 48
Interspecies transmission and host restriction of avian H5N1 influenza virus
Liu, D., Liu, X., Yan, J., Liu, W., & Gao, G. F. (2009) · Science in China Series C Life Sciences · doi:10.1007/s11427-009-0062-z · Cited by 38
Prevention of lethal respiratory vaccinia infections in mice with interferon-α and interferon-γ
Liu, G., Zhai, Q., Schaffner, D., Wu, A., Yohannes, A., Robinson, T. M., Maland, M., Wells, J., Voss, T. G., Bailey, C., et al. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00358-4 · Cited by 38
“IFN-K/L and IFN-Q can induce an antiviral state by triggering the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway and eventually by inducing the 2P,5P-oligoadenylate synthetase (OAS)/RNase L and dsRNA-dependent protein kinase (PKR) [23,24].”
BackgroundBrockmeier, S. L., Lager, K. M., Grubman, M. J., Brough, D. E., Ettyreddy, D., Sacco, R. E., Gauger, P. C., Loving, C. L., Vorwald, A. C., Kehrli, M. E., et al. (2009) · Viral Immunology · doi:10.1089/vim.2008.0075 · Cited by 37
“…triggers the production of mediators like the type I interferons (IFN-a = b ), that in turn stimulate the production of antiviral mediators, such as Mx (myxovirus resistant; IFN-inducible GTPase) and PKR (double-stranded RNA-dependent protein kinase) (3,4,29) that inhibit viral replication (20).”
Fu, J. P., Chen, S. N., Zou, P., Huang, B., Guo, Z., Zeng, L. B., Qin, Q., & Nie, P. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.11.001 · Cited by 38
Takaki, H., Watanabe, Y., Shingai, M., Oshiumi, H., Matsumoto, M., & Seya, T. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.10.006 · Cited by 37
“Many viruses encode specific proteins to inhibit IFN induction or the JAK/STAT pathway (Katze et al., 2002; Sen, 2001).”
BackgroundRisk assessment for long- and short-range airborne transmission of SARS-CoV-2, indoors and outdoors
Poydenot, F., Abdourahamane, I., Caplain, E., Der, S., Haiech, J., Jallon, A., Khoutami, I., Loucif, A., Marinov, E., & Andreotti, B. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac223 · Cited by 48
Hansson, M. J., Moss, S. J., Bobardt, M. D., Chatterji, U., Coates, N., Garcia-Rivera, J. A., Elmér, E., Kendrew, S. G., Leyssen, P., Neyts, J. H., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.10.023 · Cited by 37
“It is therefore tempting to speculate that cyclophilin inhibitors may be a step in the direction of agents with broad antiviral activity (Katze et al., 2002).”
Effector Genes of Interferon Action Against Hepatitis C Virus
Gale, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50201 · Cited by 37
Self-citationAttacking pathogens through their hosts.
Kellam, P. (2006) · Genome biology · doi:10.1186/gb-2006-7-1-201 · Cited by 42
“As it is unlikely that one laboratory will generate all possible virus-induced host gene-expression data, it is clear that data sharing and integration will be required, an idea championed by the Katze laboratory through their view of a ‘virus compendium’ to capture such information [36].”
BackgroundDiop, G., Thomas Hirtzig, A., Do, H., Coulonges, C., Vasilescu, A., Labib, T., Spadoni, J., Therwath, A., Lathrop, M. G., Matsuda, F., et al. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.08.002 · Cited by 37
Interferon responses in HIV infection: from protection to disease.
Sivro, A., Su, R., Plummer, F. A., & Ball, T. B. (2014) · PubMed · Cited by 35
Pathogenesis of Viral Respiratory Infection
Eugenia, M., Patricia, D., Horacio, L., Ocadiz‐Delgado, R., & Cabello-Gutiérrez, C. (2013) · InTech eBooks · doi:10.5772/54287 · Cited by 36
“Another mechanism involves the NS1 Protein, which can block the role of interferon [15].”
BackgroundRIG-I activation inhibits HIV replication in macrophages
Wang, Y., Wang, X., Li, J., Zhou, Y., & Ho, W. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313158 · Cited by 42
“We found that RIG-I signaling of macrophages induced ISGs (ISG15, ISG56, MxA, OAS-1, OAS-2, and Viperin) expression (Fig.”
BackgroundInfluentialHIV-1 at the placenta: immune correlates of protection and infection
Johnson, E. L., & Chakraborty, R. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000267 · Cited by 48
“These complexes translocate to the nucleus and bind interferon-stimulated response elements in DNA to activate the transcription of hundreds of interferonstimulated genes, which mediate a number of important intracellular processes [34,35], including facilitating potent antiviral responses [36,37].”
BackgroundMemory CD8+ T Cell Responses Expand When Antigen Presentation Overcomes T Cell Self-Regulation
Cockburn, I. A., Chakravarty, S., Overstreet, M. G., García‐Sastre, A., & Zavala, F. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.64 · Cited by 36
“Vaccinia virus has within its genome a number of immune evasion genes which may allow it to evade clearance by CD8 T cells and allow it to persist long enough to target Ag to DCs (51), although, unlike other poxviruses, vaccinia virus does not appear to interfere with MHC class I Ag processing (52).”
BackgroundJi, J., Glaser, A., Wernli, M., Berke, J. M., Moradpour, D., & Erb, P. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/002923-0 · Cited by 36
“In turn, HCV has evolved different strategies to overcome the antiviral effects of interferons (reviewed by Chung et al., 2007; Katze et al., 2002).”
Tasaka‐Fujita, M., Sakamoto, N., Itakura, Y., Nakagawa, M., Itsui, Y., Sekine‐Osajima, Y., Nishimura‐Sakurai, Y., Chen, C., Yoneyama, M., Fujita, T., et al. (2007) · Journal of General Virology · doi:10.1099/vir.0.83056-0 · Cited by 44
“These features have led to speculation that HCV escapes from or attenuates the host antiviral response (Katze et al., 2002).”
BackgroundFunctional genomics in virology and antiviral drug discovery
DeFilippis, V. R., Raggo, C. M., Moses, A. V., & Früh, K. (2003) · Trends in biotechnology · doi:10.1016/s0167-7799(03)00207-5 · Cited by 39
“ISGs create a cellular state in which virus replication is blocked and thus there is natural selective pressure to circumvent or impair this host response (for a recent review see [18] ).”
BackgroundBarzegar, M., Houshi, S., Sadeghi, E., Hashemi, M. S., Pishgahi, G., Bagherieh, S., Afshari-Safavi, A., Mirmosayyeb, O., Shaygannejad, V., & Zabeti, A. (2022) · Multiple Sclerosis International · doi:10.1155/2022/9388813 · Cited by 40
Zhu, W., Zhao, S., Liu, Z., Cheng, L., Wang, Q., Yan, K., Chen, Q., Wu, H. J., & Han, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402706 · Cited by 41
“IFNs subsequently upregulate numerous antiviral proteins in autocrine and paracrine manners and sculpt adaptive immune responses against invading viruses (18).”
BackgroundSong, C., Yu, S., Duan, Y., Hu, Y. H., Qiu, X., Tan, L., Sun, Y., Wang, M., Cheng, A., & Ding, C. (2013) · Archives of Virology · doi:10.1007/s00705-013-1900-7 · Cited by 35
Characterisation of chicken viperin
Goossens, K. E., Karpala, A. J., Rohringer, A., Ward, A. C., & Bean, A. G. D. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.09.011 · Cited by 36
Contribution of innate immune cells to pathogenesis of severe influenza virus infection
Cole, S., & Ho, L. (2017) · Clinical Science · doi:10.1042/cs20160484 · Cited by 38
Qi, H., Chu, V., Wu, N. C., Chen, Z., Truong, S., Brar, G., Su, S.-Y., Du, Y., Arumugaswami, V., Olson, C. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614623114 · Cited by 34
“However, it has also been recognized that viruses encode multiple mechanisms to evade these antiviral actions of the IFN response (13, 15, 51).”
BackgroundCell death‐independent functions of granzymes: hit viruses where it hurts
van Domselaar, R., & Bovenschen, N. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.697 · Cited by 48
Johnston, J. B., Nazarian, S. H., Natale, R., & McFadden, G. (2004) · Virology · doi:10.1016/j.virol.2004.11.030 · Cited by 35
“The importance of the IFN family in controlling viral infections is well established (Katze et al., 2002); thus, it is not surprising that the antiviral effects mediated by these cytokines can profoundly influence virus–host interactions.”
Dar, A. M., Munir, S., Vishwanathan, S., Manuja, A., Griebel, P. J., Tikoo, S. K., Townsend, H. G. G., Potter, A. A., Kapur, V., & Babiuk, L. A. (2005) · Virus Research · doi:10.1016/j.virusres.2005.01.006 · Cited by 38
Ostertag, D. G., Hoblitzell-Ostertag, T. M., & Perrault, J. (2006) · Journal of Virology · doi:10.1128/jvi.01218-06 · Cited by 38
“NS1A(1-73) expresses only the N-terminal RNA-binding domain of NS1A, while NS1A* expresses a mutant protein (R38A/K41A) lacking dsRNAbinding activity.”
BackgroundMethodInfluentialInterferon gene regulation: not all roads lead to Tolls
Jefferies, C. A., & Fitzgerald, K. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.07.006 · Cited by 36
Functional Heterogeneity in the CD4+ T Cell Response to Murine γ-Herpesvirus 68
Hu, Z., Blackman, M. A., Kaye, K. M., & Usherwood, E. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401928 · Cited by 35
“both innate and adaptive antiviral responses (50, 51).”
BackgroundTipping the Balance: Antagonism of PKR Kinase and ADAR1 Deaminase Functions by Virus Gene Products
George, C. X., Li, Z., Okonski, K. M., Toth, A. M., Wang, Y., & Samuel, C. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0065 · Cited by 38
Human T-cell leukemia virus type 1 blunts signaling by interferon alpha
Feng, X., & Ratner, L. (2008) · Virology · doi:10.1016/j.virol.2007.12.036 · Cited by 43
“Viruses have developed various mechanisms for initiating virus replication in the host by disrupting the actions of IFN or evading IFN-stimulated responses (Sen, 2001; Levy and Garcia-Sastre, 2001; Katze et al, 2002; Garcia-Sostre, 2002).”
BackgroundActivation of the ER stress gene gadd153 by hepatitis C virus sensitizes cells to oxidant injury
Ciccaglione, A. R., Marcantonio, C., Tritarelli, E., Equestre, M., Vendittelli, F., Costantino, A., Geraci, A., & Rapicetta, M. (2007) · Virus Research · doi:10.1016/j.virusres.2007.02.006 · Cited by 35
Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection
Lewis, D. B., & Wilson, C. B. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6400-8.00004-3 · Cited by 41
Contribution of interferon‐β to the immune activation induced by double‐stranded DNA
Shirota, H., Ishii, K. J., Takakuwa, H., & Klinman, D. M. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02367.x · Cited by 34
Regulation of type I and type III interferon induction in response to pathogen sensing
Gewaid, H. E., & Bowie, A. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102424 · Cited by 37
Wang, Y. E., Pernet, O., & Lee, B. (2011) · Biology of the Cell · doi:10.1111/boc.201100105 · Cited by 37
Monkey Viperin Restricts Porcine Reproductive and Respiratory Syndrome Virus Replication
Fang, J., Wang, H., Bai, J., Zhang, Q., Li, Y., Liu, F., & Jiang, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156513 · Cited by 33
“Phosphorylated STAT1 and STAT2 along with IRF9 form the ISGF3 complex, and the ISGF3 complex is translocated into the nucleus to bind IFN-stimulated response elements (ISREs), which results in the induction of numerous IFN-stimulated genes (ISGs) that interfere with multiple stages of the virus life cycle and limit vi…”
BackgroundRole of the Immune System Elements in Pulmonary Arterial Hypertension
Tomaszewski, M., Bębnowska, D., Hrynkiewicz, R., Dworzyński, J., Niedźwiedzka‐Rystwej, P., Kopeć, G., & Grywalska, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163757 · Cited by 36
“IFN-γ, in also acting as an effector cytokine, is a key regulator of macrophage activation through the JAK/STAT signaling pathway [90], and increases the expression of adhesion molecules, the influx of neutrophils and macrophages to the site of inflammation, as well as the expression of MHC type I and II molecules.”
BackgroundEvasion of I Interferon-Mediated Innate Immunity by Pseudorabies Virus
Zhang, R., & Tang, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.801257 · Cited by 38
“The OAS family belongs to the ISG family and produces 2′– 5′ oligoadenylates, which trigger RNA degradation by activating RNase L (Kristiansen et al., 2011).”
BackgroundModeling insights into SARS-CoV-2 respiratory tract infections prior to immune protection
Chen, A. J., Wessler, T., Daftari, K., Hinton, K. Y., Boucher, R. C., Pickles, R. J., Freeman, R., Lai, S. K., & Forest, M. G. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.04.003 · Cited by 35
“While we focus model simulations in the immediate hours and days (up to 1week) after exposure,we acknowledge that some immune response, especially interferon signaling (see (1,2)), is often triggeredwithin these timescales.”
Protective Role of Interferon Regulatory Factor 3-Mediated Signaling against Prion Infection
Ishibashi, D., Atarashi, R., Fuse, T., Nakagaki, T., Yamaguchi, N., Satoh, K., Honda, K., & Nishida, N. (2012) · Journal of Virology · doi:10.1128/jvi.06326-11 · Cited by 36
“Accumulating evidence indicates that many viruses have evolved to evade the innate immune system, including IRF3-mediated signaling (15, 23).”
Backgroundda Silva, L. F., & Jones, C. (2013) · Virus Research · doi:10.1016/j.virusres.2013.04.005 · Cited by 35
“In general, dsRNA (PolyI:C for example) induces the IFN-β signaling pathway and protein synthesis is inhibited, reviewed in (Clemens and Elia, 1997; Katze et al., 2002; Virus Res.”
BackgroundKrug, L. T., Pozharskaya, V. P., Yu, Y., Inoue, N., & Offermann, M. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8359-8371.2004 · Cited by 33
“Furthermore, viral infection stimulates many cells to secrete type I IFN and other cytokines (42, 48, 62, 88).”
BackgroundAnti-HIV State but Not Apoptosis Depends on IFN Signature in CD4+ T Cells
Audigé, A., Urosevic, M., Schlaepfer, E., Walker, R., Powell, D., Hallenberger, S., Joller, H., Simon, H., Dummer, R., & Speck, R. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6227 · Cited by 36
“Importantly, the majority of up-regulated immune response genes were ISGs, a large family of genes induced by type I IFNs and involved in mediating IFN effects (25, 26) (Figs.”
BackgroundInterferon-inducible MyD88 protein inhibits hepatitis B virus replication
Xiong, W., Wang, X., Liu, X., Li, X., Zheng, L., & Yuan, Z. (2004) · Virology · doi:10.1016/j.virol.2003.11.005 · Cited by 38
Loving, C. L., Brockmeier, S. L., Vincent, A. L., Lager, K. M., & Sacco, R. E. (2008) · Viral Immunology · doi:10.1089/vim.2008.0038 · Cited by 35
“Type I interferon (IFN- / ) plays a significant role in the innate antiviral immune response by stimulating the production of antiviral mediators, such as Mx (myxovirus resistant; IFN-inducible GTPase) and PKR (double-stranded RNAdependent protein kinase) (3,4,33), which inhibit viral replication (22).”
Choi, C., Choi, Y.-C., Park, I.-B., Lee, C., Kang, S. J., & Chun, T. (2018) · Veterinary Microbiology · doi:10.1016/j.vetmic.2018.10.005 · Cited by 33
Inhibition of neurosphere proliferation by IFNγ but not IFNβ is coupled to neuronal differentiation
Lum, M., Croze, E., Wagner, C., McLenachan, S., Mitrovic, B., & Turnley, A. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.10.009 · Cited by 33
Upregulation of a Small Subset of Genes Drives Type I Interferon-Induced Antiviral Memory
Jaitin, D. A., & Schreiber, G. (2007) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.0162 · Cited by 37
Robert-Tissot, C., Rüegger, V. L., Cattori, V., Meli, M. L., Riond, B., Gomes-Keller, M. A., Vögtlin, A., Wittig, B., Juhls, C., Hofmann‐Lehmann, R., et al. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.06.005 · Cited by 33
“Indeed, many viruses have evolutionarily acquired sophisticated strategies to counteract the IFN system (Katze et al., 2002).”
BackgroundThe Domain Landscape of Virus-Host Interactomes
Zheng, L., Li, C., Ping, J., Zhou, Y., Li, Y., & Hao, P. (2014) · BioMed Research International · doi:10.1155/2014/867235 · Cited by 36
“The smart virus takes advantage of this characteristic to evolve an efficient strategy of hijacking central proteins and interfering with the regulated network, aiming to complete its own life cycle [3, 4].”
BackgroundWu, Z., Sinzger, C., Reichel, J. J., Just, M., & Mertens, T. (2014) · Journal of Virology · doi:10.1128/jvi.03489-14 · Cited by 32
“IFN- and IFN- are produced by most cells as a direct response to viral infection, while IFN- is synthesized almost exclusively by activated NK cells and activated T cells in response to virus-infected cells (30).”
Background
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.